Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.70), versus ($0.97) reported last year. Revenue for the quarter came in at $942 million, versus $627 million reported last year.

For earnings history and earnings-related data on Dynavax (DVAX) click here.